Delivery Order SPE2DB24D2216-SPE2DB25FGNLX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,635.46 by the Defense Logistics Agency on June 13, 2025, with an ultimate completion date of June 16, 2025. The contract, which carries no set-aside designation, calls for the delivery of Belbuca 300 microgram film (60 count), a buccal film formulation used for pain management. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency issued a $1,471.48 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Belbuca 750 mcg film (60-count) with ultimate completion by April 23, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and vaccines to Defense Health Agency and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,856.59 to supply Belbuca 300 MCG Film in a quantity of 60 units. This competitive award, issued on September 22, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 23, 2025. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency issued a $1,605.19 delivery order to Amerisourcebergen Drug Corp on April 24, 2026, for Belbuca 900 mcg film 60s pharmaceutical supply, with ultimate completion by April 27, 2026. Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen Drug Corp operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems, holding a single-award indefinite delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,743.95 delivery order for Belbuca 600 microgram film (60 units) on December 4, 2025, with a completion date of December 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a transactional procurement under AmerisourceBergen's broader relationship with the federal government's medical...
- <p>The Defense Logistics Agency issued a $1,083.12 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Belbuca 750 mcg film (60-count), with an ultimate completion date of April 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., operating as a pharmaceutical distributor and medical supplier to Defense Health Agency and military medical facilities.</p>
- On January 15, 2026, the Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG Film in a quantity of 60 units, valued at $1,137.81 under a firm fixed-price contract. The award represents a non-competitive delivery order issued without set-aside designation, with an ultimate completion date of January 16, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a subsidiary of Cencora,...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on May 11, 2026, for Belbuca 450 microgram film, 60 count, with a ceiling value of $2,823.28. Place of performance is Conshohocken, PA. The order is firm fixed-price with an ultimate completion date of May 12, 2026. This is a transactional pharmaceutical delivery order typical of AmerisourceBergen's high-volume activity under DLA Troop Support Medical indefinite delivery contracts serving Defense Health Agency...
- The Defense Logistics Agency Troop Support Medical awarded a $215,150 firm fixed price delivery order to Amerisourcebergen Drug Corporation for BELBUCA 300 MCG FILM 60S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania within the period of performance from August 24-25, 2023. The Defense Logistics Agency utilizes indefinite delivery vehicle contracts to support its medical supply needs...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNLXDelivery Order
The Defense Logistics Agency awarded a $4,043.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Belbuca 750 microgram film (60 count). This is a non-set-aside competitive award with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of April 25, 2025. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company supplies an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This delivery order for Belbuca—a pain management pharmaceutical—exemplifies the company's ongoing role in fulfilling Defense Logistics Agency medical supply requirements through the DLA's flexible contract vehicle that supports the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 4/24/25 |